Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/04/24
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024GlobeNewsWire • 03/19/24
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceGlobeNewsWire • 10/30/23
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFOGlobeNewsWire • 10/27/23
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/07/23
Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)GlobeNewsWire • 08/28/23
Opthea to Feature at the American Society of Retina Specialists 2023 Annual MeetingGlobeNewsWire • 07/13/23
Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical AdvisorGlobeNewsWire • 07/10/23